CYP 2.33% 21.0¢ cynata therapeutics limited

Ann: Cynata GvHD Trial Meets all Safety & Efficacy Endpoints, page-39

  1. 3,936 Posts.
    lightbulb Created with Sketch. 1345
    Who's of the tolley? Did I mention Tech ?. NO.
    I was simply correcting a statement that was factually wrong.
    Is CYP cells better than MSB ? Well, may be, I wouldn't be checking in if I thought that they didn't at least have a chance to be better.
    Pfeifer 1982 last post : No they're not MSB cells. The boys over there ,are, borrowed IP That's why the financial payment and royalties. Anyway the trial data is good and has been approved. Price is what's been questioned and that has very little to do with manufacturing costs. To me it seems like a fairly normal process that in the end will hopefully be good for all parties.
    Best wishes to all.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
-0.005(2.33%)
Mkt cap ! $37.91M
Open High Low Value Volume
21.0¢ 21.0¢ 20.5¢ $11.26K 53.68K

Buyers (Bids)

No. Vol. Price($)
1 7339 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 32225 2
View Market Depth
Last trade - 15.39pm 23/08/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.